Edition:
United Kingdom

RaQualia Pharma Inc (4579.T)

4579.T on Tokyo Stock Exchange

1,127JPY
22 Nov 2017
Change (% chg)

-- (--)
Prev Close
¥1,127
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,318,264
52-wk High
¥1,908
52-wk Low
¥371

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 142.44 -9.164
Jun '17 45.78 -11.514
Mar '17 417.79 -3.436
FY 2016 Dec '16 66.64 -9.556
Sep '16 21.50 -16.359
Jun '16 12.50 -17.612
Mar '16 604.60 4.730
FY 2015 Dec '15 87.47 -19.851
Sep '15 13.03 -36.165
Jun '15 32.50 -34.293
Mar '15 12.50 -27.779
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.15 32.96
P/E High - Last 5 Yrs. -- 40.78 45.57
P/E Low - Last 5 Yrs. -- 23.79 24.35
Beta 1.44 0.90 0.89
Price to Sales (TTM) 38.50 3.94 5.25
Price to Book (MRQ) 5.80 4.83 5.40
Price to Tangible Book (MRQ) 5.82 5.47 6.74
Price to Cash Flow (TTM) -- 23.18 23.58
% Owned Institutions -- 0.77 1.29

Dividends

  Company industry sector
Dividend Yield -- 1.54 1.48
Dividend Yield - 5 Year Avg 0.00 1.54 1.49
Dividend 5 Year Growth Rate -- 4.38 5.23
Payout Ratio(TTM) -- 45.05 43.12

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 266.22 3.32 8.84
Sales (TTM) vs TTM 1 Yr. Ago -23.12 4.75 5.41
Sales - 5 Yr. Growth Rate 0.61 10.23 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago 34.63 16.20 19.37
EPS (TTM) vs TTM 1 Yr. Ago 40.69 -- --
EPS - 5 Yr. Growth Rate -- 10.04 10.96
Capital Spending - 5 Yr. Growth Rate 18.38 15.37 15.32

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 17.77 2.12 2.20
Current Ratio (MRQ) 17.83 2.91 3.00
LT Debt to Equity (MRQ) 0.00 8.63 10.82
Total Debt to Equity (MRQ) 0.00 12.47 14.95
Interest Coverage (TTM) -33.13 37.12 33.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 77.74 54.92 54.68
Gross Margin - 5 Yr. Avg. -- 52.01 52.16
EBITD Margin (TTM) -155.72 -- --
EBITD - 5 Yr. Avg -739.66 18.41 15.51
Operating Margin (TTM) -171.23 14.62 9.27
Operating Margin - 5 Yr. Avg. -781.66 14.52 11.18
Pre-Tax Margin (TTM) -140.34 15.10 10.08
Pre-Tax Margin - 5 Yr. Avg. -571.21 14.85 11.61
Net Profit Margin (TTM) -140.20 11.35 6.37
Net Profit Margin - 5 Yr. Avg. -573.46 11.16 7.88
Effective Tax Rate (TTM) -- 23.30 23.20
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.03

Efficiency

  Company industry sector
Revenue/Employee (TTM) 11,034,060 967,481,648 876,729,110
Net Income/Employee (TTM) -15,470,140 113,847,927 103,151,977
Receivable Turnover (TTM) -- 5.62 5.78
Inventory Turnover (TTM) 14.58 2.58 3.35
Asset Turnover (TTM) 0.13 0.96 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -18.39 11.53 11.10
Return on Assets - 5 Yr. Avg. -25.55 13.15 12.57
Return on Investment (TTM) -19.65 14.99 14.58
Return on Investment - 5 Yr. Avg. -26.72 17.20 16.46
Return on Equity (TTM) -19.81 16.33 16.09
Return on Equity - 5 Yr. Avg. -27.58 18.16 17.62
  1 Year 3 Year 5 Year
Sales % 384.70 45.69 0.61
EPS (TTM) % 66.68 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for RaQualia Pharma Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 8.67 2.64 79 25
13 Week -5.40 -9.89 39 36
26 Week 154.73 124.93 98 30
52 Week 158.92 107.78 97 12
YTD 178.54 150.71 98 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 1
Total Shares Held: 800
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.